세포 선별 시장(2026-2030년)

The global cell sorting market is forecasted to grow by USD 175458.1 thousand during 2025-2030, accelerating at a CAGR of 8.5% during the forecast period. The report on the global cell sorting market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating demand for personalized medicine and targeted immunotherapies, rapid expansion of cell and gene therapy clinical trials worldwide, surge in public and private investments for advanced biomedical research.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global cell sorting market is segmented as below:

By End-User

• Pharma and biotech companies
• Hospitals and testing labs
• Others

By Technology

• FADS
• MACS
• MEMS

By Product

• Consumables and reagents
• Instruments
• Software and services

Geography

• North America
  • US
  • Canada
  • Mexico
• Asia
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of ai and microfluidic innovations as one of the prime reasons driving the global cell sorting market growth during the next few years. Also, transition toward compact and user friendly benchtop cell sorting platforms and rising adoption of closed system architectures for enhanced biosafety and sterility will lead to sizable demand in the market.

The report on the global cell sorting market covers the following areas:

• Global cell sorting market sizing
• Global cell sorting market forecast
• Global cell sorting market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global cell sorting market vendors that include A. Menarini Industrie Farma, Apogee Flow Systems Ltd., Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Cytek Biosciences Inc., Cytonome ST LLC, Elvesys SAS, Fluigent SA, Meteor Biotech, Miltenyi Biotec BV and Co. KG, NanoCellect Biomedical Inc., Nova Biomedical Corp., On Chip Biotechnologies Co. Ltd., RainBio Solutions, Sony Biotechnology Inc., STEMCELL Technologies Inc., Stratedigm Inc., Sysmex Corp., Thermo Fisher Scientific Inc., ThinkCyte K.K., Union Biometrica Inc.. Also, the global cell sorting market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Cell Sorting Market 2020 - 2024
  • Historic Market Size - Data Table on Global Cell Sorting Market 2020 - 2024 ($ thousand)
• 5.2 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ thousand)
• 5.3 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ thousand)
• 5.4 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ thousand)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ thousand)

6 Qualitative Analysis

• 6.1 Impact of AI on global cell sorting market
• 6.2 Impact of geopolitical conflicts on global cell sorting market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by End-user

• 8.1 Market segments
• 8.2 Comparison by End-user
• 8.3 Pharma and biotech companies - Market size and forecast 2025-2030
• 8.4 Hospitals and testing labs - Market size and forecast 2025-2030
• 8.5 Others - Market size and forecast 2025-2030
• 8.6 Market opportunity by End-user
  • Market opportunity by End-user ($ thousand)

9 Market Segmentation by Technology

• 9.1 Market segments
• 9.2 Comparison by Technology
• 9.3 FADS - Market size and forecast 2025-2030
• 9.4 MACS - Market size and forecast 2025-2030
• 9.5 MEMS - Market size and forecast 2025-2030
• 9.6 Market opportunity by Technology
  • Market opportunity by Technology ($ thousand)

10 Market Segmentation by Product

• 10.1 Market segments
• 10.2 Comparison by Product
• 10.3 Consumables and reagents - Market size and forecast 2025-2030
• 10.4 Instruments - Market size and forecast 2025-2030
• 10.5 Software and services - Market size and forecast 2025-2030
• 10.6 Market opportunity by Product
  • Market opportunity by Product ($ thousand)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Asia - Market size and forecast 2025-2030
  • 12.4.1 China - Market size and forecast 2025-2030
  • 12.4.2 Japan - Market size and forecast 2025-2030
  • 12.4.3 India - Market size and forecast 2025-2030
  • 12.4.4 South Korea - Market size and forecast 2025-2030
  • 12.4.5 Indonesia - Market size and forecast 2025-2030
  • 12.4.6 Thailand - Market size and forecast 2025-2030
• 12.5 Europe - Market size and forecast 2025-2030
  • 12.5.1 Germany - Market size and forecast 2025-2030
  • 12.5.2 UK - Market size and forecast 2025-2030
  • 12.5.3 France - Market size and forecast 2025-2030
  • 12.5.4 Italy - Market size and forecast 2025-2030
  • 12.5.5 Spain - Market size and forecast 2025-2030
  • 12.5.6 The Netherlands - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 South Africa - Market size and forecast 2025-2030
  • 12.6.5 Turkey - Market size and forecast 2025-2030
  • 12.6.6 Argentina - Market size and forecast 2025-2030
  • 12.6.7 Colombia - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ thousand)
  • Data Tables on Market opportunity by geography ($ thousand)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Escalating demand for personalized medicine and targeted immunotherapies
  • Rapid expansion of cell and gene therapy clinical trials worldwide
  • Surge in public and private investments for advanced biomedical research
• 13.2 Market challenges
  • Prohibitive instrumentation costs and shortage of specialized personnel
  • Absence of standardized protocols across complex cytometric workflows
  • Difficulties associated with high dimensional data management and interpretation
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Integration of AI and microfluidic innovations
  • Transition toward compact and user friendly benchtop cell sorting platforms
  • Rising adoption of closed system architectures for enhanced biosafety and sterility

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 A. Menarini Industrie Farma
  • A. Menarini Industrie Farma - Overview
  • A. Menarini Industrie Farma - Product / Service
  • A. Menarini Industrie Farma - Key offerings
  • SWOT
• 15.5 Apogee Flow Systems Ltd.
  • Apogee Flow Systems Ltd. - Overview
  • Apogee Flow Systems Ltd. - Product / Service
  • Apogee Flow Systems Ltd. - Key offerings
  • SWOT
• 15.6 Beckman Coulter Inc.
  • Beckman Coulter Inc. - Overview
  • Beckman Coulter Inc. - Product / Service
  • Beckman Coulter Inc. - Key offerings
  • SWOT
• 15.7 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.8 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.9 Fluigent SA
  • Fluigent SA - Overview
  • Fluigent SA - Product / Service
  • Fluigent SA - Key offerings
  • SWOT
• 15.10 Meteor Biotech
  • Meteor Biotech - Overview
  • Meteor Biotech - Product / Service
  • Meteor Biotech - Key offerings
  • SWOT
• 15.11 Miltenyi Biotec BV and Co. KG
  • Miltenyi Biotec BV and Co. KG - Overview
  • Miltenyi Biotec BV and Co. KG - Product / Service
  • Miltenyi Biotec BV and Co. KG - Key offerings
  • SWOT
• 15.12 NanoCellect Biomedical Inc.
  • NanoCellect Biomedical Inc. - Overview
  • NanoCellect Biomedical Inc. - Product / Service
  • NanoCellect Biomedical Inc. - Key offerings
  • SWOT
• 15.13 Nova Biomedical Corp.
  • Nova Biomedical Corp. - Overview
  • Nova Biomedical Corp. - Product / Service
  • Nova Biomedical Corp. - Key offerings
  • SWOT
• 15.14 Sony Biotechnology Inc.
  • Sony Biotechnology Inc. - Overview
  • Sony Biotechnology Inc. - Product / Service
  • Sony Biotechnology Inc. - Key offerings
  • SWOT
• 15.15 STEMCELL Technologies Inc.
  • STEMCELL Technologies Inc. - Overview
  • STEMCELL Technologies Inc. - Product / Service
  • STEMCELL Technologies Inc. - Key offerings
  • SWOT
• 15.16 Sysmex Corp.
  • Sysmex Corp. - Overview
  • Sysmex Corp. - Business segments
  • Sysmex Corp. - Key offerings
  • Sysmex Corp. - Segment focus
  • SWOT
• 15.17 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
• 15.18 Union Biometrica Inc.
  • Union Biometrica Inc. - Overview
  • Union Biometrica Inc. - Product / Service
  • Union Biometrica Inc. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations